Friday, October 4, 2024

Canada’s Politics and Government News Source Since 1989

Friday, October 4, 2024 | Latest Paper

TRENDING:

Universal pharmacare benefits business and working families

The federal government can be on the right side of history as the upcoming election looms. Or, it can offer costly half measures that mostly benefit big pharma and the insurance industries and leave the rest of us out in the cold. The choice is clear.

Opinion
BY ANITA HUBERMAN & HASSAN YUSSUFF
February 25, 2019

Opinion | BY ANITA HUBERMAN & HASSAN YUSSUFF | February 25, 2019

See all stories BY ANITA HUBERMAN & HASSAN YUSSUFF

More Opinion

Renewable energy is the way to go, says letter writer

Canada needs a modern, national health data architecture

OpinionBY WILL FALK, TREVOR JAMIESON

To address online harms, Canada must commit to digital media literacy

OpinionBY KARA BRISSON-BOIVIN

A cure for multiple sclerosis could be just around the corner

OpinionBY PAMELA VALENTINE

Supporting local broadcasters is critical for our democracy

OpinionBY ALEX FREEDMAN

Related Stories

Pharmacare ‘feels closer now than ever before,’ but advocacy groups split on design

NewsBY EMILY HAWS

Pharmacare not really the answer to lowering drug prices, say industry associations

NewsBY EMILY HAWS

Pharmacare: don’t let NAFTA 2.0 stand in the way

Pharmacare for kids: From Ontario’s lips to the feds’ ears

OpinionBY DR. AVRAM DENBURG, DR. WENDY UNGAR

Liberal MPs push for pharmacare, while Health minister says drug costs must first be controlled

FeatureBY CHRISTOPHER GULY